<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Blood</journal-id>
      <journal-id journal-id-type="iso-abbrev">Blood</journal-id>
      <journal-id journal-id-type="hwp">bloodjournal</journal-id>
      <journal-id journal-id-type="publisher-id">Blood</journal-id>
      <journal-title-group>
        <journal-title>Blood</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-4971</issn>
      <issn pub-type="epub">1528-0020</issn>
      <publisher>
        <publisher-name>American Society of Hematology</publisher-name>
        <publisher-loc>Washington, DC</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34818416</article-id>
      <article-id pub-id-type="pmc">8900277</article-id>
      <article-id pub-id-type="publisher-id">2021/BLD2021012334</article-id>
      <article-id pub-id-type="doi">10.1182/blood.2021012334</article-id>
      <article-categories>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>29</subject>
          <subject>36</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Letters to Blood</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic toggle="yes">RACGAP1</italic> variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0889-032X</contrib-id>
          <name>
            <surname>Wontakal</surname>
            <given-names>Sandeep N.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="FM1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Britto</surname>
            <given-names>Mishan</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="FM1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Huan</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="FM1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Yongshuai</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Chengjie</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tannenbaum</surname>
            <given-names>Sarah</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8090-5448</contrib-id>
          <name>
            <surname>Durham</surname>
            <given-names>Benjamin H.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Margaret T.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>An</surname>
            <given-names>Xiuli</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8908-7485</contrib-id>
          <name>
            <surname>Mishima</surname>
            <given-names>Masanori</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY;</aff>
      <aff id="aff2"><label>2</label>Centre for Mechanochemical Cell Biology &amp; Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom;</aff>
      <aff id="aff3"><label>3</label>Laboratory of Membrane Biology, New York Blood Center, New York, NY;</aff>
      <aff id="aff4"><label>4</label>Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; and</aff>
      <aff id="aff5"><label>5</label>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
      <author-notes>
        <fn id="FM1" fn-type="equal">
          <label>*</label>
          <p>S.N.W., M.B., and H.Z. contributed equally as first authors.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>3</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>03</day>
        <month>3</month>
        <year>2022</year>
      </pub-date>
      <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>.-->
      <volume>139</volume>
      <issue>9</issue>
      <fpage>1413</fpage>
      <lpage>1418</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>4</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted-manuscript">
          <day>24</day>
          <month>11</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2022 by The American Society of Hematology. Licensed under <ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode" ext-link-type="uri">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)</ext-link>, permitting only noncommercial, nonderivative use with attribution. All other rights reserved.</copyright-statement>
        <copyright-year>2022</copyright-year>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="bloodBLD2021012334.pdf"/>
      <funding-group>
        <award-group id="sp1">
          <funding-source>
<institution-wrap><institution>National Institutes of Health</institution></institution-wrap>
</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p><bold>TO THE EDITOR</bold>:</p>
    <p>Congenital dyserythropoietic anemias (CDAs) are rare disorders defined by morphologic abnormalities of erythroid precursors that lead to ineffective erythropoiesis.<xref rid="B1" ref-type="bibr"><sup>1,2</sup></xref> CDA type III (CDA III), characterized by multinucleated erythroblasts in the bone marrow, represents the rarest form, with only &#x223C;60 patients described in the literature. Studies in 2 independent families identified a causative dominant missense mutation in <italic toggle="yes">KIF23</italic>, which encodes MKLP1,<xref rid="B3" ref-type="bibr"><sup>3</sup></xref> the kinesin subunit of centralspindlin, a key regulator of cytokinesis.<xref rid="B4" ref-type="bibr"><sup>4</sup></xref> In addition to the familial cases, a few sporadic cases of CDA III have been reported indicating an autosomal recessive pattern of inheritance.<xref rid="B1" ref-type="bibr"><sup>1,2</sup></xref> However, no genetic cause has been identified in such cases. Here, we describe a sporadic CDA III case associated with compound heterozygous variants in <italic toggle="yes">RACGAP1</italic>, which encodes CYK4/MgcRacGAP, the other subunit of centralspindlin. We demonstrate these variants cause cytokinesis failure in human erythroid cells as a result of altered target specificity in Rho-family GTPase signaling.</p>
    <p>The proband initially presented at age 3 years with unexplained macrocytic anemia that has persisted throughout his life, although never requiring a transfusion (supplemental Figure 1A). After ruling out common causes of macrocytic anemia, a bone marrow biopsy was performed. Marked dyserythropoiesis with megaloblastoid changes accompanied by multinucleated erythroid precursors and characteristic gigantoblasts were seen in &#x223C;25% of erythroblasts (<xref rid="F1" ref-type="fig">Figure 1A</xref>), establishing the diagnosis of CDA III. Clinical whole-exome sequencing did not find the previously reported pathogenic <italic toggle="yes">KIF23</italic> mutation<xref rid="B3" ref-type="bibr"><sup>3</sup></xref> or other potential deleterious variants in <italic toggle="yes">KIF23</italic>. However, compound heterozygous variants in <italic toggle="yes">RACGAP1</italic> were identified, namely, c.1187T&gt;A; p.Leu396Gln (L396Q; maternally inherited) and c.1294C&gt;T; p.Pro432Ser (P432S; paternally inherited; <xref rid="F1" ref-type="fig">Figure 1B</xref>). The parents were not anemic, as assessed by 2 independent complete blood counts (supplemental Figure 1B), suggesting both alleles are recessive. Both variants are extremely rare; they have not been seen in the genome aggregation database,<xref rid="B5" ref-type="bibr"><sup>5</sup></xref> and both variants have a combined annotation-dependent depletion score of &gt;25, with numerous other in silico algorithms predicting a deleterious effect. Indeed, they cause nonconservative amino acid substitutions of highly conserved residues in the GAP domain (<xref rid="F1" ref-type="fig">Figure 1C</xref>). These results suggest the variants identified in this patient may represent the first known genetic cause of an autosomal recessive form of CDA III.</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p><bold>Identification of a patient with CDA III who has compound heterozygous variants in <italic toggle="yes">RACGAP1</italic>.</bold> (A) Bone marrow aspirate from the proband showing a characteristic multinucleated erythroblast (top) and gigantoblast (bottom; Wright-Giemsa stain; scale bar, 10 &#x3BC;m). (B) Electropherograms of genomic DNA for the mother (top), father (middle), and proband (bottom) for variants c.1187T&gt;A (left) and c.1294C&gt;T (right). (C) Domain structure of CYK4/MgcRacGAP encoded by <italic toggle="yes">RACGAP1</italic> showing the coiled-coil (CC), C1, and RhoGAP (GTPase-activating protein [GAP]) domains as well as the MKLP1-interacting region. Sequence alignment of CYK4 orthologs shows strong conservation of the indicated residues affected by the variants. The GAP domain fragment (amino acids 343-547) was used for the biochemical assays in <xref rid="F2" ref-type="fig">Figure 2B</xref>. (D) Primary human CD34<sup>+</sup> erythroid cells were treated with short hairpin RNA (shRNA)-targeted luciferase (i) or <italic toggle="yes">RACGAP1</italic> (ii) and cultured for 15&#xA0;days. Arrows and arrowheads indicate enucleated and multinucleated cells, respectively (scale bar, 10 &#x3BC;m). (E-F) Immortalized cord blood&#x2013;derived erythroid (ImCBE) cells control depleted (luciferase) (i), <italic toggle="yes">RACGAP1</italic> depleted (ii), or <italic toggle="yes">RACGAP1</italic> depleted and rescued with an RNAi-resistant <italic toggle="yes">RACGAP1</italic> transgene (iii-v) (scale bar, 20 &#x3BC;m). (F)&#xA0;The frequency of multinucleate cells (arrowheads) in total &gt;500 cells in biologic triplicates is shown with the 95% confidence interval. The <italic toggle="yes">P</italic> values of the statistical test for the difference of the cells rescued with the P432S or L396Q variants from those rescued with the wild-type (WT) <italic toggle="yes">RACGAP1</italic> were corrected for multiple comparisons by Dunnett&#x2019;s method. ***<italic toggle="yes">P</italic> &lt; .001.</p>
      </caption>
      <graphic xlink:href="bloodBLD2021012334f1" position="float"/>
    </fig>
    <p>To determine the role of <italic toggle="yes">RACGAP1</italic> in erythroid differentiation, we performed shRNA-mediated knockdown of <italic toggle="yes">RACGAP1</italic> in primary human CD34<sup>+</sup>-derived erythroid cells.<xref rid="B6" ref-type="bibr"><sup>6</sup></xref> Efficient knockdown of <italic toggle="yes">RACGAP1</italic> (supplemental Figure 2A) did not affect terminal differentiation, as measured by surface expression of GPA (supplemental Figure 2B) or band3/&#x3B1;4 integrin (supplemental Figure 2C). However, we found a striking defect in enucleation (supplemental Figure 2D), along with a significant increase in multinucleated erythroblasts (<xref rid="F1" ref-type="fig">Figure 1D</xref>), the hallmark of CDA III. These results indicate that <italic toggle="yes">RACGAP1</italic> has critical functions in human erythropoiesis consistent with its role in the pathogenesis of CDA III.</p>
    <p>We next examined the effect of the 2 variants on <italic toggle="yes">RACGAP1</italic> function by transgene-mediated rescue of shRNA-treated erythroid cells. Technical limitations did not allow for such experiments in the primary CD34<sup>+</sup> culture system. We instead used an immortalized erythroid cell line derived from human cord blood CD34+ cells (ImCBE) (data supplement). Knockdown of <italic toggle="yes">RACGAP1</italic> in ImCBE (supplemental Figure 3) resulted in an increase of multinucleated erythroblasts (<xref rid="F1" ref-type="fig">Figure 1E-F</xref>), similar to what was observed in primary erythroid cells. ImCBE cells were transduced with an RNAi-resistant <italic toggle="yes">RACGAP1</italic> or green fluorescent protein (GFP) transgene along with the <italic toggle="yes">RACGAP1</italic>-targeting shRNA. The WT transgene efficiently suppressed the multinucleation (<xref rid="F1" ref-type="fig">Figure 1E-F</xref>). In contrast, L396Q failed to rescue the multinucleation as compared with WT (<xref rid="F1" ref-type="fig">Figure 1E-F</xref>). The effect of P432S was even more drastic, with almost no rescue of the multinucleation (<xref rid="F1" ref-type="fig">Figure 1E-F</xref>). These results demonstrate both the variants identified in the proband affect the function of <italic toggle="yes">RACGAP1</italic> in human erythropoiesis.</p>
    <p>Because both variants lie in the GAP domain of CYK4 (<xref rid="F1" ref-type="fig">Figure&#xA0;1C</xref>), we sought to understand the enzymatic effects of both variants. GAP domains stimulate the GTP hydrolysis by a GTPase, such as RhoA, Cdc42, or Rac1, using a conserved arginine residue (R385 in CYK4) and thus suppress the signaling mediated by the GTP form of these GTPases.<xref rid="B7" ref-type="bibr"><sup>7-9</sup></xref> The GAP domain of CYK4 stimulates the GTPase activity of Cdc42 and Rac1 with much greater efficiency than RhoA.<xref rid="B10" ref-type="bibr"><sup>10-13</sup></xref> The structural basis for this specificity is unclear, because most residues on the GAP-binding surface of the Rho-family GTPases are conserved (<xref rid="F2" ref-type="fig">Figure 2A</xref>; supplemental Figure 4A). We noticed that the region on CYK4 encompassing R385, L396, and P432 is located close to the GTPase residues that are distinct among RhoA, Cdc42, and Rac1<xref rid="B13" ref-type="bibr"><sup>13,14</sup></xref> (<xref rid="F2" ref-type="fig">Figure 2A</xref>; supplemental Figure 4B). Therefore, we hypothesized that the <italic toggle="yes">RACGAP1</italic> variants might affect the GAP activity of CYK4. This was tested by examining the increase of the GTPase rate by the CYK4 GAP domain<xref rid="B14" ref-type="bibr"><sup>14,15</sup></xref> (<xref rid="F2" ref-type="fig">Figure 2B</xref>; supplemental Figure 5). As expected, WT GAP showed a significantly stronger ability to stimulate the GTPase activity of Cdc42 and Rac1, as compared with that of RhoA, whereas the enzymatically inactive R385A control failed to stimulate the activity of any of the 3 GTPases (<xref rid="F2" ref-type="fig">Figure 2B</xref>). The L396Q variant showed a significant decrease in the ability to stimulate Cdc42 and Rac1 GTPases but no change in the ability to stimulate RhoA (<xref rid="F2" ref-type="fig">Figure 2B</xref>). In contrast, P432S showed no effect on Cdc42 or Rac1 but had a significant increase in the ability to stimulate RhoA GTPase (<xref rid="F2" ref-type="fig">Figure 2B</xref>). To our knowledge, this is the first mutation that significantly promotes the activity of a Rho-family GAP. These results suggest that both variants differentially affect CYK4 GAP activity to undermine its target specificity.</p>
    <fig position="float" id="F2">
      <label>Figure 2.</label>
      <caption>
        <p><bold>Molecular mechanisms of cytokinesis defects by the <italic toggle="yes">RACGAP1</italic> variants in the GAP domain.</bold> (A) Positions of the variants in a crystal structure of the CYK4 GAP domain in a complex with Cdc42 (PDB:5C2J). The arginine finger (R385) and the 2 affected residues (L396 and P432) are marked in blue, green, and magenta, respectively. The region between R385 and P432 (cyan) is located close to the 3 subtype-specific residues on the GAP-interacting surface of the GTPases (S88, E95, and N132 on CDC42). The residues of the GTPases are color coded for the difference between the subtypes of Rho GTPases (canonical Rho, Rac, and Cdc42): pink, conserved among the 3 subtypes; orange, Rho specific (ie, identical between Rac and Cdc42); green, Rac specific; khaki, Cdc42 specific; and purple, different in all 3. A closer look from a different angle and a similar mapping of the key residues on the complex with RhoA (PDB:5C2K) are found in supplemental Figure 4. (B) GAP activity (ie, the stimulation of GTPase of human RhoA, Cdc42, and Rac1 by the CYK4 GAP domain with or without mutations [WT, P432S, L396Q, and R385A]). Kinetic efficiency (<italic toggle="yes">k</italic><sub>cat</sub>/<italic toggle="yes">K</italic><sub>M</sub>) was estimated with a linear model between the rate of GAP-stimulated GTPase activity vs the concentration of the GTPase (supplemental Figure 5) and shown with standard error. <italic toggle="yes">P</italic> values of the statistical test for the difference from the control (WT GAP) were corrected for multiple comparisons by Dunnett&#x2019;s method. (C) Cell division of the HeLa cell lines stably expressing GFP-tagged CYK4 WT or variants as well as the control cell line expressing GFP alone (supplemental Figure 6 shows further characterization of the cell lines) was monitored by live microscopy after depletion of the endogenous CYK4. Frequency of cytokinesis failure calculated from the indicated numbers of failed cytokinesis in all the cell divisions in at least 3 independent experiments per line is shown with the 95% confidence interval (CI). <italic toggle="yes">P</italic> values of the statistical test for the difference from the WT cell line (w6) were corrected for multiple comparisons by Dunnett&#x2019;s method. (D) Stills from live microscopy of the cells stably expressing a GFP-tagged WT or variant CYK4 after depletion of the endogenous protein. GFP fluorescence (green) is merged on the brightfield images (grayscale; unmerged images are found in supplemental Figure 7). The transition from metaphase to anaphase was monitored by chromosomes (yellow arrowheads). Postmitotic nuclei are marked with yellow dotted curves. White arrows indicate the localization of CYK4 GFP to the spindle midzone and midbody. Magenta arrows indicate the abnormal recruitment of the P432S variant to the equatorial cortex, which failed to form a cleavage furrow. Numbers are time (minutes) after the last timeframe with aligned metaphase chromosomes (scale bar 10 &#x3BC;m). (E) Proposed model for the significance of target preference of the GAP domain of CYK4 in cytokinesis. Elevated GAP activity of the P432S variant on RhoA in combination with the reduced activity of the L396Q variant on Rac/Cdc42 disturbs the proper balance between these Rho GTPases, leading to the cytokinesis failure of erythroblasts and CDA III. *<italic toggle="yes">P</italic> &lt; .05, **<italic toggle="yes">P</italic> &lt; .01, ***<italic toggle="yes">P</italic> &lt; .001.</p>
      </caption>
      <graphic xlink:href="bloodBLD2021012334f2" position="float"/>
    </fig>
    <p>To further probe the mechanistic consequences of both variants, we established multiple independent HeLa cell lines that expressed an RNAi-resistant WT, L396Q, or P432S<xref rid="B16" ref-type="bibr"><sup>16</sup></xref> CYK4 GFP, along with a GFP-only control (<xref rid="F2" ref-type="fig">Figure 2C-D</xref>). Immunoblotting confirmed the transgenes expressed at comparable levels to the endogenous CYK4 with some variation (supplemental Figure 6A-B). Similar to what we see in erythroid cells (<xref rid="F1" ref-type="fig">Figure 1D-E</xref>), depletion of endogenous CYK4 with RNAi treatment in the GFP-only control resulted in frequent cytokinesis failure, whereas this was strongly suppressed with WT CYK4 GFP (<xref rid="F2" ref-type="fig">Figure 2C</xref>). GFP fluorescence allowed us to establish a threshold of WT CYK4 GFP levels that was necessary to significantly suppress the cytokinesis failure (supplemental Figure 6C). Using this threshold, 1 stable cell line (L15) with high expression of the L396Q transgene showed modest defects in rescuing the phenotype, whereas the other line (L6) showed much stronger defects in rescuing the cytokinesis failure (<xref rid="F2" ref-type="fig">Figure 2C</xref>). Strikingly, as observed in erythroid cells (<xref rid="F1" ref-type="fig">Figure 1E-F</xref>), the P432S transgene nearly completely failed to rescue the cytokinesis failure, regardless of the expression level (<xref rid="F2" ref-type="fig">Figure 2C</xref>; supplemental Figure 6). These results demonstrate both variants show similar defects in cytokinesis in HeLa and erythroid cells (<xref rid="F1" ref-type="fig">Figures 1E-F</xref> and <xref rid="F2" ref-type="fig">2C</xref>).</p>
    <p>Because centralspindlin functions as a key signaling hub for cytokinesis,<xref rid="B17" ref-type="bibr"><sup>17,18</sup></xref> we tested whether the variants affected CYK4 localization. As previously reported, WT CYK4 showed diffuse cytoplasmic localization during metaphase but began to accumulate at the spindle midzone at the onset of anaphase and strongly concentrated to the midbody<xref rid="B4" ref-type="bibr"><sup>4,12,16,19-21</sup></xref> (<xref rid="F2" ref-type="fig">Figure 2D</xref>; supplemental Figure 7 for unmerged images). The L396Q variant showed a similar localization pattern, although a subpopulation of the L396Q cells showed late furrow regression (<xref rid="F2" ref-type="fig">Figure 2D</xref>). In contrast, the P432S variant localized to the equatorial cell cortex with a ring-like pattern instead of accumulating at the spindle midzone (<xref rid="F2" ref-type="fig">Figure 2D</xref> magenta arrows). This abnormal localization was often accompanied by a failure to form a cleavage furrow or by formation of a transient shallow furrow that failed to complete (<xref rid="F2" ref-type="fig">Figure 2D</xref>). These results demonstrate that the severe cytokinesis defect by the P432S variant is likely due to the elevated GAP activity toward RhoA, which would interfere with the contractile ring formation, and the mislocalization of centralspindlin, whereas the modest cytokinesis defect by the L396Q variant seems to be primarily due to the diminished GAP activity toward Rac and Cdc42.<xref rid="B12" ref-type="bibr"><sup>12</sup></xref></p>
    <p>Here, we report the first known genetic cause of an autosomal recessive form of CDA III. The variants identified provide novel insights into the substrate specificity of the CYK4 GAP domain and showcase the importance of the precise balance between the activities of Rho-family GTPases during cytokinesis.<xref rid="B12" ref-type="bibr"><sup>12,22-24</sup></xref> We propose a model that tries to explain the recessive nature of the identified variants based on the altered target specificity of the CYK4 GAP domain (<xref rid="F2" ref-type="fig">Figure 2E</xref>). Interestingly, a point mutation at the corresponding residue of P432 in the <italic toggle="yes">Drosophila melanogaster</italic> ortholog was also shown to affect its in&#xA0;vivo function.<xref rid="B25" ref-type="bibr"><sup>25</sup></xref> The cortical mislocalization of the P432S variant (<xref rid="F2" ref-type="fig">Figure 2D</xref>), which exhibits elevated GAP activity against RhoA but not against Rac1 or Cdc42 (<xref rid="F2" ref-type="fig">Figure 2B</xref>), indicates the importance of the proper target specificity of the GAP domain for the subcellular localization of centralspindlin. This implies a novel mechanism for the cortical recruitment of centralspindlin via the RhoA-GAP interaction, which is hidden during normal cell division but might contribute to cleavage signaling when the central spindle is disrupted.<xref rid="B26" ref-type="bibr"><sup>26,27</sup></xref></p>
    <p>A perplexing feature of most CDAs is that variants in widely expressed genes lead mostly to erythroid-restricted phentoypes.<xref rid="B1" ref-type="bibr"><sup>1,2</sup></xref> Presumably, this reflects the erythroid-specific vulnerabilities of these genes. Indeed, it is starting to be better appreciated that distinct cell types are variably susceptible to alterations in cytokinesis machinery.<xref rid="B28" ref-type="bibr"><sup>28</sup></xref> More work is needed to address why erythroid cells are particularly vulnerable to centralspindlin dysfunction. Our findings establish that the cause of CDA III is not limited to <italic toggle="yes">KIF23</italic> but could also include other defects in centralspindlin function. Mutations in other proteins that interact and function with centralspindlin<xref rid="B29" ref-type="bibr"><sup>29</sup></xref> may also result in CDA III&#x2013;like conditions. Indeed, viewing diseases as aberrances of genetic pathways vs defects in individual genes may provide the proper framework to better understand and classify diseases.</p>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <p>The online version of this article contains a data supplement.</p>
      <supplementary-material id="SD1" position="float" content-type="local-data">
        <media xlink:href="bloodBLD2021012334-suppl1.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors thank Sergey Lekomtsev and Mark Petronczki for plasmids and Vimla Aggarwal, Julie Canman, Kartik Ganapathi, Kazutaka Murayama, Mikako Shirouzu, Steve Spitalnik, and Jenny Yang for helpful discussions and/or critical comments on the manuscript. The authors gratefully acknowledge CAMDU (Computing and Advanced Microscopy Unit) at Warwick Medical School for its support and assistance with live imaging. The Columbia University Irving Medical Center institutional review board (IRB) deemed this study exempt from IRB approval because it was considered a case study.The authors apologize to those authors whom we could not cite because of reference limitations.</p>
      <p>This work was supported by grant 1K08NS119567 from the NINDS, National Institutes of Health (NIH) (S.N.W.), program grant C19769/A11985 from Cancer Research UK (M.M.), and grants HL140625 and HL149626 from the NHLBI, NIH (X.A.).</p>
    </ack>
    <fn-group>
      <fn fn-type="supplementary-material">
        <p>The online version of this article contains a data supplement.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Authorship</title>
      <p>Contribution: S.N.W. designed research studies, collected and analyzed clinical data, and wrote the manuscript; M.B. designed research studies, performed and analyzed enzymatic assays and HeLa cell studies, and edited the manuscript; H.Z., C.G., and Y.H. designed research studies and performed and analyzed studies in erythroid cells; S.T., B.H.D., and M.T.L. collected and analyzed clinical data; X.A. designed research studies, analyzed data, and edited the manuscript; and M.M. designed research studies, analyzed data, and wrote the manuscript.</p>
      <p>Conflict-of-interest disclosure: The authors declare no competing financial interests.</p>
      <p>Correspondence: Sandeep N. Wontakal, Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032; e-mail: <email xlink:href="mailto:sw2869@cumc.columbia.edu">sw2869@cumc.columbia.edu</email>; Masanori Mishima, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom; e-mail: <email xlink:href="mailto:m.mishima@warwick.ac.uk">m.mishima@warwick.ac.uk</email>; and Xiuli An, Laboratory of Membrane Biology, New York Blood Center, New York, NY 10065; e-mail: <email xlink:href="mailto:xan@nybc.org">xan@nybc.org</email>.</p>
    </sec>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iolascon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Andolfo</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Russo</surname>
<given-names>R</given-names></string-name></person-group>. <article-title>Congenital dyserythropoietic anemias</article-title>. <source>Blood.</source>
<year>2020</year>;<volume>136</volume>(<issue>11</issue>):<fpage>1274</fpage>-<lpage>1283</lpage>.<pub-id pub-id-type="pmid">32702750</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iolascon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Heimpel</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wahlin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tamary</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Congenital dyserythropoietic anemias: molecular insights and diagnostic approach</article-title>. <source>Blood.</source>
<year>2013</year>; <volume>122</volume>(<issue>13</issue>):<fpage>2162</fpage>-<lpage>2166</lpage>.<pub-id pub-id-type="pmid">23940284</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liljeholm</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Irvine</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Vikberg</surname>
<given-names>A-L</given-names></string-name>, <etal/></person-group>. <article-title>Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23</article-title>. <source>Blood.</source>
<year>2013</year>;<volume>121</volume>(<issue>23</issue>):<fpage>4791</fpage>-<lpage>4799</lpage>.<pub-id pub-id-type="pmid">23570799</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mishima</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kaitna</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Glotzer</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity</article-title>. <source>Dev Cell.</source>
<year>2002</year>;<volume>2</volume>(<issue>1</issue>):<fpage>41</fpage>-<lpage>54</lpage>.<pub-id pub-id-type="pmid">11782313</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karczewski</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Francioli</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Tiao</surname>
<given-names>G</given-names></string-name>, <etal/>; <collab>Genome Aggregation Database Consortium</collab></person-group>. <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans [published correction appears in <italic toggle="yes">Nature</italic>. 2021;590(7846):E53]</article-title>. <source>Nature.</source>
<year>2020</year>;<volume>581</volume>(<issue>7809</issue>):<fpage>434</fpage>-<lpage>443</lpage>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Qu</surname>
<given-names>X</given-names></string-name>, <etal/></person-group>. <article-title>Distinct roles for TET family proteins in regulating human erythropoiesis</article-title>. <source>Blood.</source>
<year>2017</year>;<volume>129</volume>(<issue>14</issue>):<fpage>2002</fpage>-<lpage>2012</lpage>.<pub-id pub-id-type="pmid">28167661</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nassar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hoffman</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Manor</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Clardy</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Cerione</surname>
<given-names>RA</given-names></string-name></person-group>. <article-title>Structures of Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP</article-title>. <source>Nat Struct Biol.</source>
<year>1998</year>;<volume>5</volume>(<issue>12</issue>):<fpage>1047</fpage>-<lpage>1052</lpage>.<pub-id pub-id-type="pmid">9846874</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rittinger</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Eccleston</surname>
<given-names>JF</given-names></string-name>, <etal/></person-group>. <article-title>Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP</article-title>. <source>Nature.</source>
<year>1997</year>;<volume>388</volume>(<issue>6643</issue>):<fpage>693</fpage>-<lpage>697</lpage>.<pub-id pub-id-type="pmid">9262406</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rittinger</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Eccleston</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Smerdon</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Gamblin</surname>
<given-names>SJ</given-names></string-name></person-group>. <article-title>Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue</article-title>. <source>Nature.</source>
<year>1997</year>;<volume>389</volume>(<issue>6652</issue>):<fpage>758</fpage>-<lpage>762</lpage>.<pub-id pub-id-type="pmid">9338791</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jantsch-Plunger</surname>
<given-names>V</given-names></string-name>, <string-name><surname>G&#xF6;nczy</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Romano</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>CYK-4: a Rho family gtpase activating protein (GAP) required for central spindle formation and cytokinesis</article-title>. <source>J Cell Biol.</source>
<year>2000</year>;<volume>149</volume>(<issue>7</issue>):<fpage>1391</fpage>-<lpage>1404</lpage>.<pub-id pub-id-type="pmid">10871280</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tour&#xE9;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dorseuil</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Morin</surname>
<given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells</article-title>. <source>J Biol Chem.</source>
<year>1998</year>;<volume>273</volume>(<issue>11</issue>):<fpage>6019</fpage>-<lpage>6023</lpage>.<pub-id pub-id-type="pmid">9497316</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bastos</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Penate</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Bates</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hammond</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>FA</given-names></string-name></person-group>. <article-title>CYK4 inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytokinesis</article-title>. <source>J Cell Biol.</source>
<year>2012</year>;<volume>198</volume>(<issue>5</issue>):<fpage>865</fpage>-<lpage>880</lpage>.<pub-id pub-id-type="pmid">22945935</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amin</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Jaiswal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Derewenda</surname>
<given-names>U</given-names></string-name>, <etal/></person-group>. <article-title>Deciphering the molecular and functional basis of RHOGAP family proteins: a systematic approach toward selective inactivation of Rho family proteins</article-title>. <source>J Biol Chem.</source>
<year>2016</year>;<volume>291</volume>(<issue>39</issue>):<fpage>20353</fpage>-<lpage>20371</lpage>.<pub-id pub-id-type="pmid">27481945</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Structural basis for the specific recognition of RhoA by the dual GTPase-activating protein ARAP3</article-title>. <source>J Biol Chem.</source>
<year>2016</year>;<volume>291</volume>(<issue>32</issue>):<fpage>16709</fpage>-<lpage>16719</lpage>.<pub-id pub-id-type="pmid">27311713</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>ZX</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>Characterization of the interactions between the small GTPase Cdc42 and its GTPase-activating proteins and putative effectors. Comparison of kinetic properties of Cdc42 binding to the Cdc42-interactive domains</article-title>. <source>J Biol Chem.</source>
<year>1997</year>;<volume>272</volume>(<issue>35</issue>):<fpage>21999</fpage>-<lpage>22007</lpage>.<pub-id pub-id-type="pmid">9268338</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lekomtsev</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>K-C</given-names></string-name>, <string-name><surname>Pye</surname>
<given-names>VE</given-names></string-name>, <etal/></person-group>. <article-title>Centralspindlin links the mitotic spindle to the plasma membrane during cytokinesis</article-title>. <source>Nature.</source>
<year>2012</year>; <volume>492</volume>(<issue>7428</issue>):<fpage>276</fpage>-<lpage>279</lpage>.<pub-id pub-id-type="pmid">23235882</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mishima</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Centralspindlin in Rappaport&#x2019;s cleavage signaling</article-title>. <source>Semin Cell Dev Biol.</source>
<year>2016</year>;<volume>53</volume>:<fpage>45</fpage>-<lpage>56</lpage>.<pub-id pub-id-type="pmid">26964770</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>D&#x2019;Avino</surname>
<given-names>PP</given-names></string-name>, <string-name><surname>Giansanti</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Petronczki</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Cytokinesis in animal cells</article-title>. <source>Cold Spring Harb Perspect Biol.</source>
<year>2015</year>;<volume>7</volume>(<issue>4</issue>):<fpage>a015834</fpage>.<pub-id pub-id-type="pmid">25680833</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirose</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kawashima</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Iwamoto</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Nosaka</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kitamura</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody</article-title>. <source>J Biol Chem.</source>
<year>2001</year>;<volume>276</volume>(<issue>8</issue>):<fpage>5821</fpage>-<lpage>5828</lpage>.<pub-id pub-id-type="pmid">11085985</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hutterer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Glotzer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mishima</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Clustering of centralspindlin is essential for its accumulation to the central spindle and the midbody</article-title>. <source>Curr Biol.</source>
<year>2009</year>;<volume>19</volume>(<issue>23</issue>):<fpage>2043</fpage>-<lpage>2049</lpage>.<pub-id pub-id-type="pmid">19962307</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolfe</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Takaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Petronczki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Glotzer</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to&#xA0;initiate cleavage furrow formation</article-title>. <source>PLoS Biol.</source>
<year>2009</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e1000110</fpage>.<pub-id pub-id-type="pmid">19468300</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhuravlev</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hirsch</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Jordan</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Dumont</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shirasu-Hiza</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Canman</surname>
<given-names>JC</given-names></string-name></person-group>. <article-title>CYK-4 regulates Rac, but not Rho, during cytokinesis</article-title>. <source>Mol Biol Cell.</source>
<year>2017</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1258</fpage>-<lpage>1270</lpage>.<pub-id pub-id-type="pmid">28298491</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basant</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Glotzer</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Spatiotemporal regulation of RhoA during cytokinesis</article-title>. <source>Curr Biol.</source>
<year>2018</year>;<volume>28</volume>(<issue>9</issue>):<fpage>R570</fpage>-<lpage>R580</lpage>.<pub-id pub-id-type="pmid">29738735</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bement</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Leda</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Moe</surname>
<given-names>AM</given-names></string-name>, <etal/></person-group>. <article-title>Activator-inhibitor coupling between Rho signalling and actin assembly makes the cell cortex an excitable medium</article-title>. <source>Nat Cell Biol.</source>
<year>2015</year>;<volume>17</volume>(<issue>11</issue>):<fpage>1471</fpage>-<lpage>1483</lpage>.<pub-id pub-id-type="pmid">26479320</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Das</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shah</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Fan</surname>
<given-names>B</given-names></string-name>, <etal/></person-group>. <article-title>Spindle assembly and chromosome segregation requires central spindle proteins in drosophila oocytes</article-title>. <source>Genetics.</source>
<year>2016</year>;<volume>202</volume>(<issue>1</issue>):<fpage>61</fpage>-<lpage>75</lpage>.<pub-id pub-id-type="pmid">26564158</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verbrugghe</surname>
<given-names>KJC</given-names></string-name>, <string-name><surname>White</surname>
<given-names>JG</given-names></string-name></person-group>. <article-title>SPD-1 is required for the formation of the spindle midzone but is not essential for the completion of cytokinesis in C. elegans embryos</article-title>. <source>Curr Biol.</source>
<year>2004</year>;<volume>14</volume>(<issue>19</issue>): <fpage>1755</fpage>-<lpage>1760</lpage>.<pub-id pub-id-type="pmid">15458647</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adriaans</surname>
<given-names>IE</given-names></string-name>, <string-name><surname>Basant</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ponsioen</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Glotzer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lens</surname>
<given-names>SMA</given-names></string-name></person-group>. <article-title>PLK1 plays dual roles in centralspindlin regulation during cytokinesis</article-title>. <source>J Cell Biol.</source>
<year>2019</year>;<volume>218</volume>(<issue>4</issue>):<fpage>1250</fpage>-<lpage>1264</lpage>.<pub-id pub-id-type="pmid">30728176</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HX</given-names></string-name>, <string-name><surname>Romano Spica</surname>
<given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>Cell-intrinsic and -extrinsic mechanisms promote cell-type-specific cytokinetic diversity</article-title>. <source>Elife.</source>
<year>2018</year>;<volume>7</volume>:<fpage>e36204</fpage>.<pub-id pub-id-type="pmid">30028292</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Capalbo</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bassi</surname>
<given-names>ZI</given-names></string-name>, <string-name><surname>Geymonat</surname>
<given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis</article-title>. <source>Nat Commun.</source>
<year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>4513</fpage>.<pub-id pub-id-type="pmid">31586073</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>